Education
About Us
Working with TipRanks
Follow Us
Lauren Merendino Insider Profile
4 Followers
Lauren Merendino, CCO at Myovant Sciences, holds 0.00 shares in Myovant Sciences (Ticker: MYOV), holds ― shares in ESSA Pharma (Ticker: EPIX), holds 35.16K shares in Day One Biopharmaceuticals (Ticker: DAWN).
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-151.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Lauren Merendino holds in companies
Most Profitable Insider Trade
Stock:
Myovant Sciences
(MYOV)
(MYOV)
Rating:Informative Sell
Date:Jul 20, 2022 - Jul 20, 2023
Return:-120.00%
The most profitable trade made by Lauren Merendino
Lauren Merendino's Trading History
Myovant Sciences
Mar 10, 2023
―
Uninformative Sell
―
$0.00
ESSA Pharma
―
Director
―
―
Day One Biopharmaceuticals
May 19, 2025
Chief Commercial Officer
Uninformative Buy
40.71K
$233.82K
List of latest transactions for each holding click on a transaction to see Lauren Merendino's performance on stock
You May Also Like
Lauren Merendino insider profile FAQ
What is the percentage of profitable transactions made by Lauren Merendino?
The percentage of profitable transactions made by Lauren Merendino is 0%.
What is the average return per transaction made by Lauren Merendino?
The average return per transaction made by Lauren Merendino is -151.50%.
What stocks does Lauren Merendino hold?
Lauren Merendino holds: MYOV, EPIX, DAWN stocks.
What was Lauren Merendino’s latest transaction?
Lauren Merendino latest transaction was an Uninformative Sell of ―.
What was Lauren Merendino's most profitable transaction?
Lauren Merendino’s most profitable transaction was an Informative Sell of MYOV stock on July 20, 2022. The return on the trade was -120.00%.
What is Lauren Merendino's role in Myovant Sciences?
Lauren Merendino's role in Myovant Sciences is CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.